The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aptinyx, Inc. | Common | 03836N103 | 17,934 | 5,305,872 | SH | SOLE | 5,305,872 | 0 | 0 | ||
Corvus Pharmaceuticals, Inc. | Common | 221015100 | 13,135 | 3,275,616 | SH | SOLE | 3,275,616 | 0 | 0 | ||
Crispr Therapeutics AG | Common | H17182108 | 1,854 | 22,163 | SH | OTR | 22,163 | 0 | 0 | ||
Fusion Pharmaceuticals, Inc. | Common | 36118A100 | 39,994 | 3,502,425 | SH | SOLE | 3,502,425 | 0 | 0 | ||
Futu Holdings Limited | Class A | 36118L106 | 401 | 14,015 | SH | OTR | 14,015 | 0 | 0 | ||
GSX Techedu, Inc. | ADS | 36257Y109 | 4,607 | 51,131 | SH | OTR | 51,131 | 0 | 0 | ||
Health Catalyst, Inc. | Common | 42225T107 | 6,639 | 201,548 | SH | SOLE | 201,548 | 0 | 0 | ||
IVERIC Bio, Inc. | Common | 46583P102 | 870 | 154,271 | SH | OTR | 154,271 | 0 | 0 | ||
PagerDuty, Inc. | Common | 69553P100 | 1,564 | 57,689 | SH | OTR | 57,689 | 0 | 0 | ||
Paylocity Holding Corporation | Common | 70438V106 | 139,338 | 863,200 | SH | SOLE | 863,200 | 0 | 0 | ||
Progyny, Inc. | Common | 74340E10E | 1,332 | 45,263 | SH | OTR | 45,263 | 0 | 0 | ||
Q2 Holdings, Inc. | Common | 74736L109 | 70,960 | 777,562 | SH | SOLE | 777,562 | 0 | 0 | ||
Rimini Street, Inc. | Common | 76674Q107 | 76,296 | 23,694,465 | SH | SOLE | 23,694,465 | 0 | 0 | ||
Teladoc Health, Inc. | Common | 87918A105 | 4,467 | 20,377 | SH | OTR | 20,377 | 0 | 0 |